A US drugmaker producing skin creams for common conditions has raised the price of two of its treatments to almost $10,000 a tube in the latest instance of “gouging” in the world’s largest healthcare market, according to figures seen by the Financial Times.
根据英国《金融时报》看到的数字，美国一家生产皮肤病药膏的制药商最近把两款药膏的价格提高至每支近1万美元，尽管该公司的产品只是用来治疗常见症状。这是manbetx app苹果 最大医疗保健市场最新的“哄抬价格”例证。
您已阅读12%（352字），剩余88%（2523字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。